ZA969625B - 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols - Google Patents

25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols

Info

Publication number
ZA969625B
ZA969625B ZA969625A ZA969625A ZA969625B ZA 969625 B ZA969625 B ZA 969625B ZA 969625 A ZA969625 A ZA 969625A ZA 969625 A ZA969625 A ZA 969625A ZA 969625 B ZA969625 B ZA 969625B
Authority
ZA
South Africa
Prior art keywords
cholecalciferols
bishomo
ene
hydroxy
Prior art date
Application number
ZA969625A
Other languages
English (en)
Inventor
Jerome Anthony Iacobelli
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA969625B publication Critical patent/ZA969625B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C07C45/305—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385—Saturated compounds containing a keto group being part of a ring
    • C07C49/487—Saturated compounds containing a keto group being part of a ring containing hydroxy groups
    • C07C49/507—Saturated compounds containing a keto group being part of a ring containing hydroxy groups polycyclic
    • C07C49/513—Saturated compounds containing a keto group being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA969625A 1995-11-22 1996-11-15 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols ZA969625B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US874495P 1995-11-22 1995-11-22

Publications (1)

Publication Number Publication Date
ZA969625B true ZA969625B (en) 1997-05-22

Family

ID=21733405

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA969625A ZA969625B (en) 1995-11-22 1996-11-15 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols

Country Status (27)

Country Link
US (1) US6030963A (xx)
EP (1) EP0874814B1 (xx)
JP (2) JP3917184B2 (xx)
KR (1) KR19990071535A (xx)
CN (1) CN1076347C (xx)
AR (1) AR004726A1 (xx)
AT (1) ATE241599T1 (xx)
AU (1) AU705942B2 (xx)
BR (1) BR9611741A (xx)
CA (1) CA2237897C (xx)
CZ (1) CZ293489B6 (xx)
DE (1) DE69628458T2 (xx)
DK (1) DK0874814T3 (xx)
EA (1) EA002772B1 (xx)
ES (1) ES2198501T3 (xx)
HU (1) HUP9903715A3 (xx)
IL (1) IL124290A (xx)
MX (1) MX9803966A (xx)
MY (1) MY116582A (xx)
NO (1) NO982304L (xx)
NZ (1) NZ322035A (xx)
PL (1) PL186845B1 (xx)
PT (1) PT874814E (xx)
TR (1) TR199800908T2 (xx)
TW (1) TW403735B (xx)
WO (1) WO1997019058A1 (xx)
ZA (1) ZA969625B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939408A (en) * 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
GB9625271D0 (en) * 1996-12-04 1997-01-22 Leo Pharm Prod Ltd Chemical compounds
US5919986A (en) * 1997-10-17 1999-07-06 Hoffmann-La Roche Inc. D-homo vitamin D3 derivatives
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
BRPI0404050A (pt) * 2003-09-24 2005-06-14 Bioxell Spa Uso de um composto ou de um seu sal ou éster farmaceuticamente aceitável, formulação farmacêutica, formulação acondicionada, composto, e, método para prevenir e/ou tratar hiperplasia benigna da próstata em pacientes em necessidade de tal prevenção ou tratamento
AU2004275845A1 (en) * 2003-09-24 2005-04-07 Bioxell, S.P.A. Methods for treating bladder dysfunction
US7332482B2 (en) * 2003-09-24 2008-02-19 Bioxell S.P.A. Method for treating benign prostatic hyperplasia
AU2005289664A1 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
EP2682386B1 (en) * 2011-03-02 2016-08-17 Nihon University Novel vitamin d receptor modulator with partial agonist activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
TW267161B (xx) * 1992-11-20 1996-01-01 Hoffmann La Roche

Also Published As

Publication number Publication date
HUP9903715A3 (en) 2000-09-28
CZ157298A3 (cs) 1998-09-16
JP3917184B2 (ja) 2007-05-23
CZ293489B6 (cs) 2004-05-12
AU705942B2 (en) 1999-06-03
CN1076347C (zh) 2001-12-19
AU7570296A (en) 1997-06-11
PL326837A1 (en) 1998-10-26
DE69628458D1 (de) 2003-07-03
JP2000500476A (ja) 2000-01-18
NO982304L (no) 1998-07-07
CA2237897A1 (en) 1997-05-29
EA002772B1 (ru) 2002-08-29
CN1202885A (zh) 1998-12-23
BR9611741A (pt) 1999-02-23
TR199800908T2 (xx) 2001-05-21
NO982304D0 (no) 1998-05-20
AR004726A1 (es) 1999-03-10
EP0874814A1 (en) 1998-11-04
TW403735B (en) 2000-09-01
KR19990071535A (ko) 1999-09-27
EP0874814B1 (en) 2003-05-28
MY116582A (en) 2004-02-28
DK0874814T3 (da) 2003-09-22
IL124290A (en) 2002-09-12
ATE241599T1 (de) 2003-06-15
DE69628458T2 (de) 2004-03-18
EA199800468A1 (ru) 1998-12-24
US6030963A (en) 2000-02-29
MX9803966A (es) 1998-09-30
ES2198501T3 (es) 2004-02-01
NZ322035A (en) 1998-11-25
WO1997019058A1 (en) 1997-05-29
HUP9903715A2 (hu) 2000-03-28
CA2237897C (en) 2006-01-03
PL186845B1 (pl) 2004-03-31
PT874814E (pt) 2003-09-30
JP2007126458A (ja) 2007-05-24

Similar Documents

Publication Publication Date Title
ZA967315B (en) Biphenylamides.
MX213417B (es) Fenilpiridazinonas.
ZA9610858B (en) Heteroclyclic compounds.
ZA961444B (en) Pyrazolylbenzoyl derivatives.
HUP9602745A3 (en) Anticelladhesive piperidine- und pyrrolidine-carbonacids, pharm
ZA964468B (en) Triazolylmethyl-cyclopentanols.
DE69628446D1 (en) Polycarbonatharz, vernetztes polycarbonatharz und elektrophotographischer photorezeptor
ZA961955B (en) Indazolecarboxamides.
ZA961449B (en) Isoxazolylbenzoyl derivatives.
EP0664969A3 (de) Skischuh.
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA967741B (en) Diarylalkenylamine derivatives.
ZA969625B (en) 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA966399B (en) Endothelin-receptor-antagonists.
ZA964560B (en) Anit-viral compounds.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
EP0684299A3 (de) Dihydrofarnesal.
ZA966750B (en) Halogenobenzimidazoles.
ZA966933B (en) Endothelin-receptor-antagonists.
ZA967314B (en) Carbamoylcarboxamides.
ZA964034B (en) N-aminopyridone derivatives.
GR3034943T3 (en) Medrogestrone.